| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$230,344 |
|
|
|
Indirect Value
|
$201,533 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$431,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-05 |
4 |
AS |
$49.51 |
$218,756 |
I/I |
(4,400) |
166,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-06 |
4 |
AS |
$46.53 |
$208,532 |
I/I |
(4,400) |
162,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-26 |
4 |
AS |
$40.01 |
$177,370 |
I/I |
(4,400) |
158,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-09-28 |
4 |
AS |
$21.40 |
$96,300 |
I/I |
(4,500) |
406,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-21 |
4 |
AS |
$43.60 |
$198,965 |
I/I |
(4,500) |
229,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-22 |
4 |
AS |
$42.74 |
$201,832 |
I/I |
(4,600) |
225,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-06-08 |
4 |
AS |
$20.79 |
$99,792 |
I/I |
(4,800) |
344,311 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-06-23 |
4 |
AS |
$21.19 |
$101,712 |
I/I |
(4,800) |
339,511 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-06-24 |
4 |
AS |
$21.32 |
$102,336 |
I/I |
(4,800) |
334,711 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-07 |
4 |
AS |
$22.80 |
$109,440 |
I/I |
(4,800) |
329,911 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-08 |
4 |
AS |
$22.96 |
$110,208 |
I/I |
(4,800) |
325,111 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-20 |
4 |
AS |
$21.99 |
$105,552 |
I/I |
(4,800) |
320,311 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-07-21 |
4 |
AS |
$22.22 |
$106,656 |
I/I |
(4,800) |
315,511 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-08-22 |
4 |
AS |
$22.58 |
$108,384 |
I/I |
(4,800) |
430,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-08-23 |
4 |
AS |
$22.08 |
$105,984 |
I/I |
(4,800) |
425,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,907 |
41,532 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,907 |
223,228 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,907 |
725,951 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
47,440 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
217,321 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
229,136 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
555,044 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
731,859 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
737,767 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
743,675 |
0 |
- |
|
209 Records found
|
|
Page 7 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
